Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Allison

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1990
Expression of a T cell receptor gamma-chain (V gamma 1.1J gamma 4C gamma 4) transgene in mice influences T cell receptor ontogeny and thymic architecture during developmentD A Ferrick, A Chan, A Rahemtulla, et al.
The Journal of Experimental Medicine|September 19, 2001
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responsesR P Sutmuller, L M van Duivenvoorde, A van Elsas, et al.
The Journal of Experimental Medicine|August 22, 2001
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapyA van Elsas, R P Sutmuller, A A Hurwitz, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patientsV Gopalakrishnan, C N Spencer, L Nezi, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1990
Expression of a T cell receptor gamma-chain (V gamma 1.1J gamma 4C gamma 4) transgene in mice influences T cell receptor ontogeny and thymic architecture during developmentD A Ferrick, A Chan, A Rahemtulla, et al.
The Journal of Experimental Medicine|September 19, 2001
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responsesR P Sutmuller, L M van Duivenvoorde, A van Elsas, et al.
The Journal of Experimental Medicine|August 22, 2001
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapyA van Elsas, R P Sutmuller, A A Hurwitz, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patientsV Gopalakrishnan, C N Spencer, L Nezi, et al.
Pageof 15